Allergan, the makers of Botox Cosmetic, recently received FDA approval for a new medication- LATISSE™ (bimatoprost ophthalmic solution) 0.03%.

It is the first and only treatment approved by the FDA for inadequate or insufficient eyelashes, growing them longer, fuller and darker. The medication is only available by prescription. Patients apply Latisse topically to the base of their upper eyelashes with an applicator once a day and results are reported after 4-6 weeks.